|
Correlation between serum Sclerostin level and vascular calcification in maintenance hemodialysis patients
2020, 19 (02):
103-107.
doi: 10.3969/j.issn.1671-4091.2020.02.009
【Abstract】Objective To investigate the relationship between serum sclerostin and the degree of abdominal aortic calcification in patients undergoing maintenance hemodialysis(MHD). Methods 150 MHD patients in our hospital's nephropathy center were selected as subjects, Collect patient demographic data and clinical data, Including diabetes and residual urine volume, urine volume <200ml is considered as no residual renal function (RRF), Serum Sclerostin and bone specific alkalinephosphatase(BsAP) levels from 150 cases of MHD patients were measured by ELISA. Abdominal aortic calcification (AAC) was detected by lateral radiographs of the abdomen and AAC scores were performed. Analysis of the relationship between Sclerostin level and iPTH, BsAP and a AAC in patients with MHD. Results 1. The incidence of abdominal aortic calcification in patients with MHD was 74%. The patients were divided into calcified group and non-calcified group according to the presence or absence of AAC. The results showed that the sclerostin, kt/v in the calcified group was significantly lower than that in the non- calcified group (t=6.694, P<0.001). Age(t=- 5.250,P<0.001), dialysis age (t=-4.356,P<0.001), iPTH(t=-2.926,P<0.001), serum alkaline phosphatase (t=-3.877,P<0.001), BsAP (t=-4.654,P<0.001)were higher than those without calcification (P<0.05). There were no significant differences in gender (t=2.345,P=0.126), serum calcium (t=- 0.262,P=0.794) and phosphorus (t= 0.096,P=0.923) between the two groups (P> 0.05). 2. Logistic regression analysis of risk factors for vascular calcification in patients with MHD: Age (OR=1.134, 95% CI, 1.059~1.224, P<0.001), dialysis age (OR=1.006, 95% CI, 1.006- 1.075, P= 0.019), RRF(OR=0.150, 95%CI, 0.027~0.818, P=0.028), Diabetes (OR=8.199, 95% CI, 1.316~51.073, P=0.024), iPTH (OR= 1.009, 95% CI, 1.001~1.017,P=0.035) , Kt/V(OR=0.030, 95% CI, 0.001~0.652, P=0.026), Sclerostin (OR=0.985, 95% CI, 0.976~0.994, P=0.002), BsAP(OR=1.295, 95% CI) , 1.037~1.618, P=0.023) were statistically significant. Conclusion The incidence of vascular calcification were higher in MHD patients.Agedness,Long-dialysis, diabetes, higher iPTH, and higher BsAP are risk factors for vascular calcification in patients with MHD,but RRF, Sclerostin, and Kt/V are protective
factors for vascular calcification in patients with MHD.
Metrics
|